This biotech breakthrough allows the efficient and cost-effective production of eCells, which in turn can be used to synthesize bioproducts of high commercial value and industrial relevance.
Researchers at the Australian National University have developed a novel method for producing encapsulated cell-like structures (eCells) based on the lysate of E. coli for use in CFPS. This biotech breakthrough allows the efficient and cost-effective production of eCells, which in turn can be used to synthesize bioproducts of high commercial value and industrial relevance.